Bristol-Myers Squibb Announces Dividend Increase
NEW YORK -- December 04, 2012
The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today
declared an increase of approximately three percent in the company’s quarterly
dividend, beginning in the first quarter of 2013.
The dividend increase will result in a quarterly dividend of thirty-five cents
($0.35) per share on the $0.10 par value Common Stock of the corporation for
an indicative 2013 full-year dividend of $1.40 per share, subject to the
normal quarterly review by the Board. The next quarterly dividend will be
payable on February 1, 2013, to stockholders of record at the close of
business on January 4, 2013.
The Directors also declared a quarterly dividend of fifty cents ($0.50) per
share on the $2.00 Convertible Preferred Stock of the corporation, payable
March 1, 2013, to stockholders of record at the close of business on February
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to
discover, develop and deliver innovative medicines that help patients prevail
over serious diseases. For more information, please visit www.bms.com or
follow us on Twitter at http://twitter.com/bmsnews.
Jennifer Fron Mauer, 609-252-6579
John Elicker, 609-252-4611
Press spacebar to pause and continue. Press esc to stop.